[1] Takahashi M,Tamura K,Hoshino Y,et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol,2010,82(2):271-281. [2] Villalba MC,Guan M,Perez A,et al. Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana,Cuba. Trans R Soc Trop Med Hyg,2010,104(12):772-776. [3] Bachlein C,Grummer B. Hepatitis E a new zoonotic disease in Germany Berl Munch Tierarztl Wochenschr,2010,123(5-6):198-204. [4] Tam AW,Smith MM,Guerra ME,et al. Hepatitis E virus(HEV):molecular cloning and sequencing of the full- length viralgenome. Virology,1991,185(1):120- 131. [5] Chandra V,Kar-roy A,Kumari S,et al. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking,STAT3 translocation,and the acute- phase response. J Virol,2008,82(14):7100-7110. [6] Moin SM,Panteva M,Jameel S. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem,2007,282 (29):21124-21133. [7] Tyagi S,Surjit M,Lal SK. The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin,a kunitz-type serine protease inhibitor. J Virol,2005,79(18):12081-12087. [8] Tyagi S,Surjit M,Roy AK,et al. The ORF3 protein of hepatitis E virus interacts with liver- specific alpha1- microglobulin and its precursor alpha1- microglobulin/bikunin precursor(AMBP) and expedites their export from the hepatocyte. J Biol Chem, 2004,279(28):29308-29319. [9] Kar-roy A,Korkaya H,Oberoi R,et al. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem,2004, 279(27):28345-28357. [10] Tyagi S,Korkaya H,Zafrullah M,et al. The phosphorylated form of the ORF3 protein of hepatitis E virus interactswith its non- glycosylated form of the major capsid protein,ORF2. J Biol Chem,2002,277(25):22759-22767. [11] Kumar S,Subhadra S,Singh B,et al.Hepatitis E virus:the current scenari. Int J Infect Dis,2013,17(4):228-233. [12] WHO. Viral hepatitis in the WHO south-east Asia region. India: regional office for south-east Asia, 2011. [13] Emerson SU,Purcell RH. Hepatitis E virus. Rev Med Virol, 2003,13(3):145-154. [14] Dalton H R,Bendall R,Ljaz S,et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis,2008,8(11):698-709. [15] Nagashima S,Takahashi M,Jirintai H,et al.A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells.J Gen Virol,2011,92(2):269-278. [16] Kumar S,Subhadra S,Singh B,et al. Hepatitis E virus:the current scenario.Int J Infect Dis,2013,17(4):228-233. [17] Shih WL,Kuo ML,Chuang SE,et al.Hepatitis B virus X protein activates a survival signaling by linking SRC to phosphatidylinositol 3-kinase.J Biol Chem,2003,278(34): 31807-31813. [18] Georgopoulou U,Caravokiri K,Mavromara P.Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses.Arch Virol,2003,148( 2):237-251. [19] Kar-roy A, Korkaya H,Oberoi R,et al. The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem, 2004, 279(27):28345-28357. [20] Korkaya H,Jameel S,Gupta D,et al. The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK.J Biol Chem,2001,276(45):42389- 42400. [21] Panteva M, Korkaya H,Jameel S. Hepatitis viruses and the MAPK pathway:is this a survival strategy.Virus Res,2003,92(2):131-140. [22] Tyagi S,Surjit M,Roy AK,et al. The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1- microglobulin and its precursor alpha1-microglobulin/bikunin precursor(AMBP) and expedites their export from the hepatocyte. J Biol Chem, 2004,279(28):29308-29319. [23] Panda SK,Ansari IH,Durgapal H,et al. The in vitro- synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol, 2000,74(5):2430-2437. |